Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India

Back Stocks profile

Stock analysis tool for investors

Indoco Remedies Ltd.

NSE: INDOCO | BSE:532612

₹345.55 0.70 (0.20%) 1D

Pharmaceuticals & Biotechnology

Buy Sell
View detailed Technical chart

Open an Account with Bigul in 5 minutes

Performance

Today’s low

342.40

Today’s High

347.40

52W low

286.60

52W High

415.00

Open Price

346.60

Prev. Close

317.1500

Volume

42566.00

Value

14708681.30

Fundamentals

Market Cap Cr

3185.40

Price to Earnings

32.30

Price to Book Value

2.90

Dividend Yield

0.70

PE to Growth

-1.10

Op Revenue TTM Cr

1817.29

Net Profit TTM Cr

98.47

Cash From Operating Activity Cr

156.70

Return on Equity %

8.87

EMA & SMA

Bullish Moving Averages

14

Bearish Moving Averages

2

5Day EMA

337

10Day EMA

332.1

12Day EMA

330.8

20Day EMA

327.5

26Day EMA

326.4

50Day EMA

327

100Day EMA

333.6

200Day EMA

340.3

5Day SMA

333.6

10Day SMA

330.1

20Day SMA

326.1

30Day SMA

320.6

50Day SMA

323.2

100Day SMA

334.4

150Day SMA

350.8

200Day SMA

347

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

03 Jul, 2024

49.6

Week

50

Month

53.4

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

347.70

PIVOT

First Resistance

351.55

Second Resistance

358.25

Third Resistance

362.10

First Support

341.00

Second Support

337.15

Third Support

330.45

Relative Strength Index

70.45

Money Flow Index

74.62

MACD

4.42

MACD Signal

2.08

Average True Range

8.82

Average Directional Index

15.06

Rate of Change (21)

12.99

Rate of Change (125)

-11.63

Commodity Channel Index

293.2

Williams %R

-27.3

BETA

1 Month

0.49

3 Month

0.47

1 Year

0.78

3 Year

0.37

PRICE CHANGE ANALYSIS

↑ 5.88%

1 Week

Low

High

319.4

354.4

↑ 13.22%

1 Month

Low

High

286.6

354.4

↑ 0.67%

3 Months

Low

High

286.6

372

↓ -11.57%

6 Months

Low

High

286.6

415

↑ 4.92%

1 Year

Low

High

286.6

415

Indicator Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Graph
Total Qtr Revenue cr 449.54 451.98 474.51 423.29 427.95 399.01 433.03 409.03 409.17 357.92 387.60
Operating Expenses Qtr 388.13 383.76 400.97 359.97 363.29 336.99 344.93 336.60 328.41 284.36 300.27
Operating Profit Qtr 57.36 65.29 72.42 62.91 64.17 61.65 87.76 71.30 80.47 73.40 86.32
EBIDT Qtr Cr 81.14 60.02 73.54 63.32 64.66 62.02 88.10 72.43 80.76 73.56 87.33
Depreciation Qtr 23.73 22.97 21.41 19.87 17.69 17.16 15.65 20.10 18.04 19.22 19.46
Net Profit Qtr 37.56 20.01 33.14 25.94 25.37 27.87 49.64 38.47 40.37 32.97 41.57
Basic EPS Qtr 4.08 2.17 3.60 2.81 2.75 3.02 5.39 4.17 4.38 3.58 4.51
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 1799.32 1669.02 1542.04 1243.42 1108.42
Operating Expenses Annual Cr 1532.83 1381.80 1212.72 1016.73 982.65
Operating Profit Annual 257.98 284.89 327.00 223.58 123.34
Operating Profit Margin Annual % 14.34 17.07 21.21 17.98 11.13
Total Expenses Annual Cr 1657.63 1477.43 1305.81 1112.06 1079.72
EBIDT Annual Cr 266.49 287.22 329.32 226.69 125.77
EBIDT Annual margin % 14.81 17.21 21.36 18.23 11.35
Depreciation 87.98 70.60 78.95 73.12 70.81
PAT Before ExtraOrdinary Items Annual Cr 116.64 141.36 154.52 92.39 24.25
Net Profit Annual 116.64 141.36 154.52 92.39 24.25
Basic EPS Annual 12.66 15.34 16.77 10.03 2.63
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 1126.62 1027.02 904.30 768.93 680.16
Minority Interest Liability Annual Cr - - - - -
Total Non Current Liabilities Annual Cr 271.74 205.41 156.57 139.10 132.98
Total Current Liabilities Annual Cr 562.25 427.24 426.70 408.54 459.17
Total Capital Plus Liabilities Annual Cr 1960.61 1659.67 1487.57 1316.57 1272.31
Fixed Assets Annual 846.77 774.03 676.52 638.01 640.32
Total Non Current Assets Annual 1060.39 852.62 714.79 694.62 710.55
Total Current Assets Annual 900.22 807.05 772.78 621.95 561.76
Total Assets Annual 1960.61 1659.67 1487.57 1316.57 1272.31
Contingent Liabilities plus Commitments Annual Cr - 83.15 60.27 55.72 51.73
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual 176.78 175.59 173.55 82.17 122.66
Cash from Investing Activity Annual -301.69 -205.31 -121.41 -66.70 -55.95
Cash from Financing Annual Activity 122.39 22.81 -44.37 -29.83 -63.95
Net Cash Flow Annual - -6.91 7.77 -14.35 2.76
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 122.19 111.45 98.13 83.44 73.81
ROE Annual % 10.35 13.76 17.08 12.01 3.56
ROCE Annual % 12.76 17.57 23.60 16.91 6.75
Total Debt to Total Equity Annual 0.46 0.31 0.27 0.28 0.30
EBDIT Annual Margin % 14.88 17.23 21.38 18.27 11.37
Indicator Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Graph
Total Qtr Revenue cr 452.30 461.77 486.16 426.91 428.66 399.56 433.39 409.35 409.43 358.16 387.88
Operating Expenses Qtr 400.77 396.52 410.36 365.33 363.40 337.16 345.19 336.77 328.59 284.55 300.43
Operating Profit Qtr 48.87 62.90 71.37 61.17 64.76 62.04 87.85 71.45 80.54 73.45 86.44
EBIDT Qtr Cr 71.26 57.05 75.80 61.58 65.26 62.40 88.20 72.58 80.84 73.61 87.45
Depreciation Qtr 26.23 24.35 21.41 19.88 17.69 17.17 15.65 20.10 18.05 19.22 19.45
Net Profit Qtr 22.70 16.30 35.08 24.39 25.81 28.14 49.73 38.57 40.45 32.99 41.69
Basic EPS Qtr 2.39 1.69 3.82 2.62 2.80 3.05 5.40 4.19 4.39 3.58 4.52
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 1827.14 1670.95 1543.08 1244.64 1109.02
Operating Expenses Annual Cr 1572.98 1382.52 1213.41 1017.26 983.37
Operating Profit Annual 244.31 286.09 327.34 224.27 123.21
Operating Profit Margin Annual % 13.37 17.12 21.21 18.02 11.11
Total Expenses Annual Cr 1702.87 1478.15 1306.51 1112.65 1080.44
EBIDT Annual Cr 254.16 288.43 329.67 227.38 125.64
EBIDT Annual margin % 13.91 17.26 21.36 18.27 11.33
Depreciation 91.87 70.61 78.96 73.13 70.82
PAT Before ExtraOrdinary Items Annual Cr 97.01 142.25 154.80 93.05 24.12
Net Profit Annual 98.47 142.25 154.80 93.05 24.12
Basic EPS Annual 10.53 15.44 16.80 10.10 2.62
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 1109.90 1028.25 904.64 768.99 679.57
Minority Interest Liability Annual Cr 0.60 0.00 0.00 0.00 0.00
Total Non Current Liabilities Annual Cr 421.90 205.44 156.60 139.15 133.04
Total Current Liabilities Annual Cr 612.33 424.51 424.85 406.92 458.99
Total Capital Plus Liabilities Annual Cr 2144.73 1658.20 1486.09 1315.06 1271.60
Fixed Assets Annual 1057.58 791.76 676.54 638.04 640.35
Total Non Current Assets Annual 1190.06 850.02 712.47 692.54 708.49
Total Current Assets Annual 954.67 808.18 773.62 622.53 563.10
Total Assets Annual 2144.73 1658.20 1486.09 1315.06 1271.60
Contingent Liabilities plus Commitments Annual Cr - 83.15 60.27 55.72 51.73
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual 156.70 178.84 173.83 82.22 122.85
Cash from Investing Activity Annual -433.83 -208.17 -121.41 -66.69 -55.93
Cash from Financing Annual Activity 280.44 22.80 -44.37 -29.87 -63.95
Net Cash Flow Annual - -6.53 8.05 -14.34 2.97
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 120.44 111.58 98.17 83.45 73.75
ROE Annual % 8.87 13.83 17.11 12.09 3.54
ROCE Annual % 10.59 17.65 23.62 16.98 6.74
Total Debt to Total Equity Annual 0.61 0.31 0.27 0.28 0.30
EBDIT Annual Margin % 13.98 17.28 21.39 18.31 11.35
Name Holding Percent Holding Id Pledged % Locked %
Icici Prudential Smallcap Fund 1.91 74803149 - -
HDFC Trustee Company Ltd A/c HDFC Capital Builder Value Fund 1.63 74803151 - -
Franklin India Smaller Companies Fund 1.48 74803152 - -
Name Holding Percent Holding Id Pledged % Locked %
PANANDIKAR ADITI MILIND 6.07 74803129 0 0
MADHURA SURESH KARE 5.64 74803130 0 0
KARE ARUNA SURESH 5.2 74803131 0 0
KARE SURESH GOVIND 4.4 74803132 0 0
SPA HOLDINGS PVT LTD 19.89 74803135 0 0
SHANTERI INVESTMENT PVT LTD 17.11 74803136 0 0
Name Holding Percent Holding Id
Nippon Life India Trustee Ltd-A/C Nippon India Small Cap Fund 4.97 74803147
Quant Mutual Fund-Quant Small Cap Fund 4.56 74803148
Icici Prudential Smallcap Fund 1.91 74803149
Dsp Healthcare Fund 1.84 74803150
HDFC Trustee Company Ltd A/c HDFC Capital Builder Value Fund 1.63 74803151
Franklin India Smaller Companies Fund 1.48 74803152
UTI Healthcare Fund 1.05 74803153
Name Holding Percent Holding Id
MANGESHI INVESTMENT PRIVATE LIMITED 1.27 74803165
Ex-Date Dividend Amount Dividend Type Record Date Instrument Type
Sep 18, 2023 2.25 FINAL - Equity Share
Sep 14, 2022 0.75 SPECIAL - Equity Share
Sep 14, 2022 1.5 FINAL - Equity Share
Sep 17, 2021 1.5 FINAL - Equity Share
Sep 18, 2020 0.3 FINAL - Equity Share
Aug 22, 2019 0.3 FINAL - Equity Share
Aug 31, 2018 1 FINAL - Equity Share
Jul 31, 2017 1.6 FINAL - Equity Share
Jul 20, 2016 0.2 FINAL - Equity Share
Mar 17, 2016 1.4 INTERIM Mar 18, 2016 Equity Share
Jul 21, 2015 1.6 FINAL - Equity Share
Jul 21, 2014 1.4 FINAL - Equity Share
Jul 19, 2013 1.1 FINAL - Equity Share
Jul 20, 2012 1.1 FINAL - Equity Share
Jul 19, 2011 8 FINAL - Equity Share
Jul 13, 2010 7 FINAL - Equity Share
Sep 09, 2009 2 FINAL - Equity Share
Dec 11, 2008 3.25 INTERIM Dec 12, 2008 Equity Share
Sep 19, 2008 5 FINAL - Equity Share
Dec 13, 2007 6.5 FINAL - Equity Share
Nov 01, 2006 6.25 FINAL - Equity Share
Sep 15, 2005 5 FINAL - Equity Share
Ex-Date Split Ratio Record Date
May 17, 2012 10:2 2012-05-19
Ex-Date Purpose Notes
May 16, 2024 Audited Results & Final Dividend -
Jan 23, 2024 Quarterly Results -
Oct 19, 2023 Quarterly Results -
Jul 25, 2023 Quarterly Results -
May 23, 2023 Audited Results & Final Dividend -
Jan 24, 2023 Quarterly Results -
Nov 10, 2022 Quarterly Results -
Aug 09, 2022 Quarterly Results -
May 17, 2022 Audited Results & Final Dividend -
Feb 01, 2022 Quarterly Results -
Nov 02, 2021 Quarterly Results -
Aug 11, 2021 Quarterly Results -
May 25, 2021 Audited Results & Final Dividend -
Feb 09, 2021 Quarterly Results -
Nov 06, 2020 Quarterly Results -
Aug 11, 2020 Quarterly Results -
Jun 24, 2020 Audited Results & Dividend -
Jan 23, 2020 Quarterly Results -
Oct 30, 2019 Quarterly Results -
Aug 13, 2019 Quarterly Results -
May 29, 2019 Audited Results & Dividend -
Jan 23, 2019 Quarterly Results -
Nov 13, 2018 Quarterly Results -
Aug 13, 2018 Quarterly Results (Revised)
May 30, 2018 Audited Results & Final Dividend -
Jan 25, 2018 Quarterly Results -
Nov 07, 2017 Quarterly Results -
Aug 09, 2017 Quarterly Results -
May 26, 2017 Audited Results & Final Dividend -
Jan 27, 2017 Quarterly Results -
Oct 26, 2016 Quarterly Results -
Jul 29, 2016 Quarterly Results -
May 27, 2016 Audited Results & Final Dividend -
Mar 10, 2016 Interim Dividend -
Jan 29, 2016 Quarterly Results -
Oct 30, 2015 Quarterly Results -
Jul 30, 2015 Quarterly Results -
May 27, 2015 Audited Results & Final Dividend -
Jan 30, 2015 Quarterly Results -
Oct 21, 2014 Quarterly Results -
Jul 30, 2014 Quarterly Results -
May 28, 2014 Audited Results & Final Dividend -
Jan 29, 2014 Quarterly Results -
Oct 30, 2013 Quarterly Results -
Jul 30, 2013 Quarterly Results -
May 28, 2013 Audited Results & Final Dividend -
Jan 29, 2013 Quarterly Results -
Nov 02, 2012 Quarterly Results -
Jul 30, 2012 Quarterly Results -
May 28, 2012 Audited Results & Dividend -
May 21, 2012 Allotment of Bonus Shares -
May 09, 2012 To fix the Record date To consider the followings: 1. To fix record date for Sub-division of Shares Rs. 10/- each to Rs. 2/- each. 2. To fix record date for issue of Bonus Shares.
Mar 29, 2012 Bonus Issue, Stock Split & Others To increase Authorized Capital from existing Rs. 18.00 Crs to Rs. 25.00 Crs, to sub-divide of Equity Shares of Rs. 10/- each to Rs. 2/-each & to issue of Bonus Shares in the ratio of 1:2.
Feb 14, 2012 Quarterly Results -
Dec 17, 2011 Resignation of Director's The Board has considered the letter of resignation received from Mr. D N Mungale, and after due deliberations it was decided to accept his resignation w.e.f December 09, 2011, as desired by him.
Oct 20, 2011 Quarterly Results -
Jul 28, 2011 Quarterly Results -
May 28, 2011 Audited Results & Final Dividend -
Apr 27, 2011 Quarterly Results -
Jan 20, 2011 Quarterly Results -
Oct 20, 2010 Quarterly Results -
Jul 22, 2010 Quarterly Results -
May 31, 2010 Audited Results & Final Dividend -
Apr 26, 2010 Quarterly Results -
Jan 27, 2010 Quarterly Results -
Oct 30, 2009 Quarterly Results -
Jul 30, 2009 Audited, Quarterly Results & F. Dividend -
Apr 29, 2009 Quarterly Results -
Jan 30, 2009 Quarterly Results -
Nov 26, 2008 Interim Dividend -
Oct 31, 2008 Quarterly Results (Revised)
Sep 05, 2008 Audited Results & Dividend (Revised)
Jul 30, 2008 Quarterly Results -
Apr 30, 2008 Quarterly Results -
Jan 29, 2008 Quarterly Results -
Oct 31, 2007 Quarterly Results -
Oct 18, 2007 Audited Results, Dividend & Qtr Results -
Apr 26, 2007 Quarterly Results -
Jan 24, 2007 Quarterly Results & Amalgamation 1. To consider the amalgamation of M/s. La Nova Chem (India) Pvt Ltd, a 100% subsidiary of the Co, with the Co. 2. To consider the acquisition of the pharmaceutical business of M/s. SPA Pharma (P) Ltd
Oct 30, 2006 Quarterly Results -
Aug 10, 2006 Accounts & Dividend -
May 19, 2006 Merger of Indoco Healthcare Ltd. To consider the merger of Indoco Healthcare Ltd., the 100% subsidiary of the Company, with the Company.
Apr 27, 2006 Quarterly Results -
Jan 24, 2006 Quarterly Results -
Oct 27, 2005 Quarterly Results -
Jul 23, 2005 Accounts & Quarterly Results -
Apr 26, 2005 Quarterly Results -
Jan 13, 2005 Quarterly results -
Ex-Date Bonus Ratio Record Date
May 17, 2012 1:2 2012-05-19
Bigul
28 Jun 2024

INDOCO REMEDIES LTD. - 532612 - Shareholder Meeting / Postal Ballot-Outcome of Postal Ballot

 Intimation under regulation 30 of SEBI (LODR)Regulations,2015-Proceeding of Postal Ballot
Bigul
28 Jun 2024

INDOCO REMEDIES LTD. - 532612 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

 Disclosure of voting results of Postal Ballot pursuant to regulation 44 of the SEBI(LODR)Regulations,2015 alongwith Scrutinizers Report.
Bigul
28 Jun 2024

INDOCO REMEDIES LTD. - 532612 - Closure of Trading Window

 Trading Window for trading/dealing in Equity Shares of the Company will remain closed from Monday, 01, July ,2024 until 48 hours after declaration of Standalone and Consolidated Financial Results of the Company for the quarter ended 30-06-2024
Bigul
19 Jun 2024

INDOCO REMEDIES LTD. - 532612 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Enclosed herewith in Annexure A the details of the notice as per Rule 99(1) in Form GST ASMT-10 received from the Goods and Service Tax (GST) Authority.
13 Jun 2024

Indoco Remedies - U.S. To Drive Growth: Nirmal Bang

 The company acquired a 85% stake in FPP for $4 million to enhance its front-end marketing and distribution strength in the U.S.
Bigul
10 Jun 2024

INDOCO REMEDIES LTD. - 532612 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aditi M Panandikar & Others
Bigul
10 Jun 2024

INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Investor Presentation

 Enclosed a copy of Investor Presentation of the Company that will be shared with the various investors/Analysts.
Bigul
10 Jun 2024

INDOCO REMEDIES LTD. - 532612 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aditi M Panandikar & Others
06 Jun 2024

USFDA Approves Indoco Remedies' Generic Diabetes Drug

 USFDA grants approval to Indoco Remedies for generic diabetes drug, Canagliflozin and Metformin Hydrochloride tablets.
Bigul
06 Jun 2024

INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Indoco Remedies receives tentative ANDA approval from USFDA for Canagliflozin and Metformin Hydrochloride Tablets
See all News

FAQs

The latest market price of Indoco Remedies Ltd. on NSE was Rs. 345.55 as of today.

The opening share price of Indoco Remedies Ltd. was Rs. 346.60 as of today.

The 52-week high share price of Indoco Remedies Ltd. was Rs. 415.00.

The 52 week low share price of Indoco Remedies Ltd. was Rs. 286.60.

Indoco Remedies Ltd. has a market cap of Rs. 3185.40 crore as of today. Please refer to the Fundamentals section for further details.

The PE ratio of Indoco Remedies Ltd. is -1.10. Please refer to the Fundamentals section for further details.

The operating revenue for Indoco Remedies Ltd. in the last FY was Rs.  1817.29 crore. Please refer to the Financials section for further details.

The Net Profit for Indoco Remedies Ltd. in the last FY was Rs. 98.47 crore. Please refer to the Financials section for further details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Indoco Remedies Ltd. was on 2023-09-18 for Rs. 2.25 per share. According to today’s share price, the dividend yield of Indoco Remedies Ltd. stands at 0.70. Please refer to the Corporate Actions section for further details.

The latest bonus issue declared by Indoco Remedies Ltd. was as of 2012-05-17. The bonus ratio declared in this issue was 1:2. Please refer to the Corporate Actions section for further details.

The latest split issue declared by Indoco Remedies Ltd. was as of 2012-05-17. The split ratio declared in this issue was 10:2. Please refer to the Corporate Actions section for further details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Indoco Remedies Ltd..

Close

Let's Open Free Demat Account